Form 4 Tracker
Christopher R. Cline

CHIEF FINANCIAL OFFICER · 6 filings · Latest: Sep 15, 2026

Travere Therapeutics, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERSep 15, 2026
Sale
$62.3450,508$3.1M87,508
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERSep 15, 2026
Option Exercise
$17.4420,000$348.8K138,016
TVTX
CHRISTOPHER CLINE—Sep 15, 2026
Proposed Sale
$65.7950,508$3.3M—
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERSep 2, 2026
Sale
$66.37642$42.6K118,016
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERMay 6, 2026
Sale
$43.95310$13.6K118,658
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERMay 5, 2026
Sale
$46.652,181$101.7K118,968
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERMay 4, 2026
Option Exercise
$0.004,250—121,149
TVTX
CHRISTOPHER CLINE—May 6, 2026
Proposed Sale
$43.95310$13.6K—
TVTX
Christopher Cline—May 5, 2026
Proposed Sale
$46.652,181$101.7K—
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERApr 15, 2026
Sale
$42.611,014$43.2K116,899
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERApr 14, 2026
Sale
$41.937,248$303.9K117,913
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERApr 13, 2026
Sale
$28.8565$1.9K125,161
TVTX
CHRISTOPHER CLINE—Apr 15, 2026
Proposed Sale
$42.611,014$43.2K—
TVTX
Christopher Cline—Apr 14, 2026
Proposed Sale
$41.937,239$303.5K—
TVTX
CHRISTOPHER CLINE—Apr 14, 2026
Proposed Sale
$41.079$370—
TVTX
Christopher Cline—Apr 13, 2026
Proposed Sale
$28.8565$1.9K—
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERFeb 4, 2026
Sale
$32.191,745$56.2K111,226
TVTX
CHRISTOPHER CLINE—Feb 4, 2026
Proposed Sale
$32.191,745$56.2K—
TVTX
Christopher Cline—Feb 3, 2026
Proposed Sale
$32.127,242$232.6K—
TVTX
Christopher R. ClineCHIEF FINANCIAL OFFICERFeb 3, 2026
Sale
$32.127,242$232.6K112,971

Page 1 of 2

Next →